Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion
A Multi-Center Prospective Randomized Study Comparing Supplemental Posterior Instrumentation, Aspen™ Spinous Process System Versus Pedicle Screw Fixation, in Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
1 other identifier
interventional
64
1 country
3
Brief Summary
The purpose of this clinical investigation is to evaluate the Aspen™ device compared to pedicle screw instrumentation for posterior fixation in the treatment of patients with degenerative disc disease and/or spondylolisthesis. The Aspen™ device will be compared to pedicle screw instrumentation in Oswestry Disability Index (ODI) improvement and success of fusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2012
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 29, 2012
CompletedFirst Posted
Study publicly available on registry
March 9, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedMarch 7, 2018
March 1, 2018
3.9 years
February 29, 2012
March 5, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Absolute change in Oswestry Disability Index (ODI)
baseline to 12 months post-operative
Secondary Outcomes (8)
Fusion success
12 months and 24 months
Neurological status
Baseline, 6 weeks, 3 months, 6 months, 12 months, & 24 months
Change in EQ-5D-3L
Baseline, 6 weeks, 3 months, 6 months, 12 months, & 24 months
Change in SF-36
Baseline, 12 months & 24 months
Change in Visual Analogue Scale (VAS) (pain)
Baseline, 6 weeks, 3 months, 6 months, 12 months, & 24 months
- +3 more secondary outcomes
Study Arms (2)
Aspen Spinous Process Fixation Device
EXPERIMENTALSubjects randomized to the Aspen study arm will have the Aspen device implanted as supplemental posterior fixation only and according to the manufacturer's recommendations.
Pedicle Screws
ACTIVE COMPARATORSubjects randomized to the pedicle screw group will have polyaxial top loading pedicle screws implanted according to the standard procedures and practices at that institution. The procedure may be performed according to surgeon preference, including a traditional open, minimally invasive or percutaneous approach. Only pedicle screws cleared by FDA for this indication will be used in this study.
Interventions
The Aspen device will be placed as posterior fixation to Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Pedicle Screws will be placed as posterior fixation to Lateral Lumbar Interbody Fusion (LLIF) or Anterior Lumbar Interbody Fusion (ALIF)
Eligibility Criteria
You may qualify if:
- Age between 18 and 75 years
- Scheduled for an elective single-level circumferential lumbar fusion by means of supplemental posterior fusion with fixation (allowing for the placement of ASPEN or pedicle screws) for an anterior or lateral interbody fusion
- Diagnosis of primary symptomatic Degenerative Disc Disease (DDD) and/or spondylolisthesis confirmed with appropriate imaging studies and/or positive lumbar discography
- Oswestry Disability Index (ODI) v2.1 score \> 30%
- Failed at least 3 months of conservative care (non-surgical) OR has clinical signs of neurological deterioration
- Signed Informed Consent Form
You may not qualify if:
- Previous fusion at the operative level
- Spondylolisthesis Grade 3 or more
- Lytic spondylolisthesis
- Incompetent or missing posterior arch at the affected level (e.g. complete laminectomy, pars defect)
- Requires complete laminectomy at level of surgery
- Facet joints at implant level are absent or fractured
- Vertebral body compromise or acute fracture at implant level
- Body mass Index (BMI) ≥ 35
- Known allergy to titanium
- Osteoporosis: Simple Calculated Osteoporosis Risk Estimation (S.C.O.R.E.) \> 6 AND Dual-energy X-ray absorptiometry (DEXA) T-score \< -2.5
- Paget's disease, osteomalacia, or any other metabolic bone disease
- Use of medications or any drug known to potentially interfere with bone/soft tissue healing (e.g. chronic systemic steroids)
- Planned use of additional segmental fixation (eg. facet screws)
- Planned use of Bone Morphogenetic Protein (BMP) for posterolateral fusion\*
- Unlikely to comply with the follow-up evaluation schedule
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
Study Sites (3)
Clint Hill
Paducah, Kentucky, 42001, United States
Buffalo Spine Surgery
Lockport, New York, 14094, United States
Andy Kranenburg
Medford, Oregon, 97504, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patel
University of Colorado, Denver
- PRINCIPAL INVESTIGATOR
Cappuccino
Buffalo Spine Surgery
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 29, 2012
First Posted
March 9, 2012
Study Start
February 1, 2012
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
March 7, 2018
Record last verified: 2018-03